Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6*2, 1A7*12, 1A8*3, 1A9*3, 2B7*2, and 2B15*2) in a Saudi population

被引:2
|
作者
Alkharfy, Khalid M. [1 ]
Jan, Basit L. [1 ]
Afzal, Sibtain [2 ,3 ]
Al-Jenoobi, Fahad I. [4 ]
Al-Mohizea, Abdullah M. [4 ]
Al-Muhsen, Saleh [2 ,3 ]
Halwani, Rabih [2 ,3 ]
Parvez, Mohammad K. [5 ]
Al-Dosari, Mohammed S. [5 ]
机构
[1] King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Med, Dept Pediat, Asthma Res Chair, Riyadh, Saudi Arabia
[3] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh, Saudi Arabia
[4] King Saud Univ, Dept Pharmaceut, Riyadh, Saudi Arabia
[5] King Saud Univ, Dept Pharmacognosy, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
关键词
Glucuronidation; UDP-glucuronosyltransferase; UGT1A; UGT2B; Saudi gene polymorphism; CANCER-PATIENTS; HUMAN LIVER; MORPHINE GLUCURONIDATION; IRINOTECAN TOXICITY; ORAL MORPHINE; HUMAN COLON; 2B7; UGT2B7; IDENTIFICATION; METABOLISM; FLAVOPIRIDOL;
D O I
10.1016/j.jsps.2016.05.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucuronidation is an important phase II pathway responsible for many endogenous substances and drug metabolism. The present work evaluated allele frequencies of certain UDP-glucuronosyl-transferases (UGT 1A6*2, A7*12, A8*3, A9*3, 2B7*2, and 2B15*2) in Saudi Arabians that could provide essential ethnic information. Blood samples from 192 healthy unrelated Saudi males of various geographic regions were collected. Genomic DNA was isolated and genotyping of various UGTs was carried out using polymerase chain reaction (PCR) followed by direct sequencing. For UGT1A6*2 A/G genotype, the most common variant was the homozygous repeat (AA) and the most common allele was (A) with a frequency of 46.5% and 67.3%, respectively. Similarly, the most common variant for UGT1A7*12 T/C genotype was the heterozygous repeat (TC) with a frequency of 78.7% while the mutant allele (C) was present in 60.6% of the study population. Both UGT1A8*3 (G/A) and UGT1A9*3 (T/C) showed only a wild homozygous pattern in all screened subjects. For UGT2B7*2, the heterozygous repeat (TC) was found with a frequency of 57.3% and the alleles (A) showed a frequency of 50.8%. In contrast, for UGT2B15*2 (G253T), the heterozygous repeat (TG) presented 62.3% of the subjects where the most common allele (G) was with a frequency of 66.2%. In conclusion, our data indicate that Saudis harbor some important UGT mutations known to affect enzyme activity. Additional studies are therefore, warranted to assess the clinical implications of these gene polymorphisms in this ethnic group. (C) 2016 The Authors.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [41] Multiple roles for udp-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution
    Gauthier-Landry, Louis
    Belanger, Alain
    Barbier, Olivier
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 145 : 187 - 192
  • [42] Bovine Serum Albumin Decreases Km Values of Human UDP-Glucuronosyltransferases 1A9 and 2B7 and Increases Vmax Values of UGT1A9
    Manevski, Nenad
    Moreolo, Paolo Svaluto
    Yli-Kauhaluoma, Jari
    Finel, Moshe
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2117 - 2129
  • [43] Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance
    Bhasker, CR
    McKinnon, W
    Stone, A
    Lo, ACT
    Kubota, T
    Ishizaki, T
    Miners, JO
    PHARMACOGENETICS, 2000, 10 (08): : 679 - 685
  • [44] Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers
    Izukawa, Takeshi
    Nakajima, Miki
    Fujiwara, Ryoichi
    Yamanaka, Hiroyuki
    Fukami, Tatsuki
    Takamiya, Masataka
    Aoki, Yasuhiro
    Ikushiro, Shin-ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1759 - 1768
  • [45] Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients
    Petrenaite, Vaiva
    Ohman, Inger
    Jantzen, Frederik Peter Thal
    Ekstrom, Lena
    EPILEPSY RESEARCH, 2022, 182
  • [46] Strong Specific Inhibition of UDP-glucuronosyltransferase 2B7 by Atractylenolide I and III
    Zhang, Qian
    Cao, Yun-Feng
    Ran, Rui-Xue
    Li, Rong-Shan
    Wu, Xue
    Dong, Pei-Pei
    Zhang, Yan-Yan
    Hu, Cui-Min
    Wang, Wei-Ming
    PHYTOTHERAPY RESEARCH, 2016, 30 (01) : 25 - 30
  • [47] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [48] Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7
    Anna Mróz
    Izabela Ryska
    Hanna Sominko
    Anna Bejrowska
    Zofia Mazerska
    Pharmacological Reports, 2018, 70 : 972 - 980
  • [49] UDP-glucuronosyltransferase 2B15 (UGT2B15) Is the Major Enzyme Responsible for Sipoglitazar Glucuronidation in Humans: Retrospective Identification of the UGT Isoform by In Vitro Analysis and the Effect of UGT2B15*2 Mutation
    Nishihara, Mitsuhiro
    Hiura, Yuto
    Kawaguchi, Naohiro
    Takahashi, Junzo
    Asahi, Satoru
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (06) : 475 - 484
  • [50] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261